Malard, Florent http://orcid.org/0000-0002-3474-0002
Battipaglia, Giorgia http://orcid.org/0000-0002-0695-3879
Gaugler, Béatrice http://orcid.org/0000-0001-9434-7176
Siblany, Lama
van de Wyngaert, Zoe
Bonnin, Agnes
Duléry, Rémy http://orcid.org/0000-0002-5024-1713
Banet, Anne
Stocker, Nicolas
Ricard, Laure
Brissot, Eolia http://orcid.org/0000-0003-4471-418X
Mohty, Mohamad
Article History
Received: 15 May 2023
Revised: 7 July 2023
Accepted: 27 July 2023
First Online: 22 August 2023
Competing interests
: FM reports lecture honoraria from, Therakos/Mallinckrodt, Janssen, Sanofi, JAZZ Pharmaceuticals, Gilead, Novartis, and Bristol Myers Squibb, all outside the submitted work. MM reports grants and lecture honoraria from Janssen, Sanofi, Maat Pharma and JAZZ Pharmaceuticals, lecture honoraria from Celgene, Amgen, BMS, Takeda, and Pfizer, grants from Roche, all outside the submitted work. The other authors declare no competing financial interests. RD reports research funding from Ligue contre le Cancer, Arthur Sachs, Monahan Foundation, Servier Foundation, Philippe Foundation, DCP AP-HP, honoraria from Novartis and Takeda, non-financial support from Kite Pharma/Gilead, all outside the submitted work.